4 free views remaining today

cystathioninuria

ICD-10 Codes

Related ICD-10:

Description

Cystathioninuria: A Rare Inborn Error of Metabolism

Cystathioninuria, also known as primary cystathioninuria, is a rare inborn error of metabolism characterized by the abnormal accumulation of plasma cystathionine and subsequent increased urinary excretion of this amino acid [1]. This condition occurs due to the deficiency of the enzyme cystathionine gamma-lyase, which is necessary for the conversion of methionine to cysteine [5].

Key Features:

  • Autosomal recessive inheritance pattern
  • Abnormal accumulation of plasma cystathionine
  • Increased urinary excretion of cystathionine
  • No striking pathologic features [3]
  • Pyridoxine-dependent, but in very rare cases [8]

Causes and Consequences:

Cystathioninuria is caused by the deficiency of cystathionine gamma-lyase, which leads to the accumulation of cystathionine in the plasma and its subsequent excretion in the urine. This condition can have significant consequences for individuals affected by it, including:

  • Elevated levels of cystathionine in the blood
  • Increased urinary excretion of cystathionine
  • Potential complications related to methionine metabolism

References:

[1] Primary Cystathioninuria is an inborn error of methionine metabolism, where the conversion of Cystathionine to Cysteine is missing the Cystathionine Gamma-Lyase.

[3] Cystathioninuria, an autosomal recessive phenotype with no striking pathologic features, is characterized by abnormal accumulation of plasma cystathionine,

[5] Hereditary cystathioninuria is caused by deficiency of the activity of cystathionine gamma-lyase, which is normally required for the conversion of methionine to cysteine.

[8] Description. Cystathioninuria is an autosomal recessive disorder caused by cystathionine gamma-lyase deficiency. It is usually pyridoxine-dependent, but in very rare cases.

Additional Characteristics

  • Cystathioninuria is a rare inborn error of metabolism characterized by the abnormal accumulation of plasma cystathionine and subsequent increased urinary excretion of this amino acid.
  • This condition occurs due to the deficiency of the enzyme cystathionine gamma-lyase, which is necessary for the conversion of methionine to cysteine.
  • Cystathioninuria can have significant consequences for individuals affected by it, including elevated levels of cystathionine in the blood and increased urinary excretion of cystathionine.

Signs and Symptoms

Cystathioninuria, also known as cystathionase deficiency or gamma-cystathionase deficiency syndrome, is a rare inherited metabolic disorder characterized by excessive amounts of undissolved cystine in the urine. The signs and symptoms of this condition can vary, but they often include:

  • Abnormally high levels of cystathionine in the urine [4]
  • Global developmental delay, which can manifest as delayed speech, language, or cognitive development [1]
  • Encephalopathy, a brain disorder that can cause seizures, behavioral disturbances, and other neurological problems [1]
  • Cytopenias, including megaloblastic anemia, which is a type of anemia characterized by large red blood cells [1]
  • Poor growth in children with cystathioninuria [1]

Additionally, some individuals with cystathioninuria may experience:

  • Intellectual disability or mental retardation [6]
  • Seizures, which can be a result of the encephalopathy associated with this condition [5, 6]
  • Behavioral and psychological disturbances, such as anxiety, depression, or other emotional problems [5]

It's worth noting that the symptoms of cystathioninuria can vary widely among affected individuals, and some people may experience only mild signs and symptoms. However, in many cases, this condition can have a significant impact on an individual's quality of life.

References: [1] Context result 1 [4] Context result 4 [5] Context result 5 [6] Context result 6

Additional Symptoms

  • Global developmental delay
  • Seizures
  • Intellectual disability
  • Encephalopathy
  • Poor growth
  • Cytopenias
  • Abnormally high levels of cystathionine in the urine
  • Behavioral and psychological disturbances

Diagnostic Tests

Diagnostic Tests for Cystathioninuria

Cystathioninuria, also known as cystathionase deficiency, can be diagnosed through various biochemical and genetic tests.

  • Biochemical testing: This involves assessing levels of cystathionine in the blood and urine. Elevated levels of cystathionine are a characteristic feature of this disorder [1][2].
  • Genetic testing: Genetic testing may allow diagnostic confirmation of cystathioninuria, especially if there is a family history of the condition [3]. This test may also be considered for reproductive partners of individuals with cystathioninuria.
  • Methionine load tests: Methionine load tests can be used to diagnose cystathioninuria. These tests involve administering methionine and measuring its levels in the blood and urine [4].
  • Plasma total homocysteine (tHcy) testing: Plasma tHcy is considered the frontline test for diagnosis of CBS deficiency, which is associated with cystathioninuria [5].

Other Diagnostic Methods

  • Stone analysis: Stone analysis can be used to determine the type of kidney stone in patients with cystathioninuria. This can help confirm the diagnosis [6].
  • Microscopic examination: Microscopic examination of the first morning urine sample can reveal pathognomonic hexagonal crystals are not specific for cystathioninuria but can be seen in up to 2/3 of untreated patients [7].

It's essential to note that a definitive diagnosis of cystathioninuria typically involves biochemical testing and genetic analysis. A healthcare professional may decide to carry out additional diagnostic tests to definitively diagnose the patient and rule out any other possible clinical disorders [8].

Treatment

Treatment Options for Cystathioninuria

Cystathioninuria, a rare inborn error of metabolism, can be managed through various treatment options. While there are no specific therapies for this condition, certain medications and dietary modifications can help alleviate symptoms.

  • Pyridoxine Therapy: Oral pyridoxine (vitamin B6) therapy has been shown to normalize biochemical parameters in individuals with cystathioninuria [1]. However, it's essential to note that this treatment does not address the underlying metabolic defect.
  • Betaine for Oral Solution (Cystadane): Although approved by the FDA as a treatment for homocystinuria due to CBS deficiency, betaine may also be beneficial in managing cystathioninuria [7].
  • Dietary Modifications: A high-cysteine diet has been recommended for individuals with cystathioninuria [4]. However, it's crucial to consult with a healthcare professional before making any significant changes to your diet.
  • Medications: While not specifically approved for cystathioninuria, medications like penicillamine have been used in the treatment of related conditions such as cystinuria [11].

Important Considerations

It's essential to note that cystathioninuria is a benign disorder that does not lead to any substantial alterations in an individual's physiological functioning [8]. However, individuals with this condition may experience developmental and intellectual delays [3].

When considering treatment options, it's crucial to consult with a healthcare professional who can provide personalized guidance based on your specific needs.

References

[1] Cystathioninuria: Management. G. W. FRIMPTER, MD; A. J. GREENBERG, MD

[3] Cystathionine Beta-Synthase Deficiency.

[4] There are no therapies specific for cysathioninuria; however, a high-cysteine diet ...

[7] Betaine for oral solution (Cystadane) is approved by the U.S. Food and Drug Administration (FDA) as a treatment for homocystinuria due to CBS deficiency.

[8] Cystathioninuria is a benign disorder that does not lead to any substantial alterations in an individual's physiological functioning in any way.

[11] Penicillamine is the first thiol drug used in cystinuria.

Recommended Medications

💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.

Differential Diagnosis

Differential Diagnosis of Cystathioninuria

Cystathioninuria, a metabolic disorder caused by the deficiency of the enzyme γ-cystathionase, can be challenging to diagnose due to its similarity in symptoms with other conditions. The following are some differential diagnoses that should be considered:

  • Remethylation defects: These defects involve the metabolism of homocysteine and methionine, which can lead to similar symptoms as cystathioninuria.
  • Transient neonatal cystathioninuria: This condition is caused by other factors such as genetic mutations or environmental influences, leading to temporary accumulation of cystathionine in the urine.
  • Primary hepatic tumors: Tumors in the liver can cause an increase in cystathionine levels, making it a differential diagnosis for cystathioninuria.
  • Sympathetic tumors: Certain types of tumors, such as neuroblastoma or ganglioneuroblastoma, can also be associated with elevated cystathionine levels.

Key Points to Consider

  • Cystathioninuria is an autosomal recessive disorder characterized by the abnormal accumulation of plasma cystathionine leading to excess cystathionine in the urine.
  • The symptoms of cystathioninuria may begin at any age, and the disease can be associated with various other conditions.
  • A thorough medical history and physical examination are essential for making an accurate diagnosis.

References

  • [1] Cystathioninuria is considered a biochemical anomaly due to its inconsistency and wide variety of disease associations (Mudd et al., 2001).
  • [2] The symptoms of cystathioninuria can be similar to those of homocystinuria caused by CBS deficiency, making differential diagnosis essential (Geiser, 1968).

Note: The numbers in square brackets refer to the context numbers provided.

Additional Differential Diagnoses

  • Remethylation defects
  • Transient neonatal cystathioninuria
  • Primary hepatic tumors
  • Sympathetic tumors

Additional Information

oboInOwl#hasOBONamespace
disease_ontology
oboInOwl#id
DOID:0090142
core#notation
DOID:0090142
oboInOwl#hasDbXref
UMLS_CUI:C0268616
oboInOwl#hasExactSynonym
gamma-cystathionase deficiency
rdf-schema#label
cystathioninuria
IAO_0000115
An amino acid metabolic disorder that is characterized by elevated plasma and urinary cystathionine levels that has_material_basis_in autosomal recessive inheritance of homozygous or compound heterozygous mutation in the gene encoding cystathionine gamma-lyase (CTH) on chromosome 1p31.
rdf-schema#subClassOf
t361475
oboInOwl#inSubset
http://purl.obolibrary.org/obo/doid#NCIthesaurus
IDO_0000664
http://purl.obolibrary.org/obo/GENO_0000148
relatedICD
http://example.org/icd10/E72.19
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class
rdf-schema#domain
https://w3id.org/def/predibionto#has_symptom_4350
owl#annotatedSource
t361392

Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.

It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.